NCT06772740

Middle Meningeal Artery Embolization for Patients With Chronic Subdural Hematoma

Randomized Clinical Trial of Middle Meningeal Artery Embolization for Patients With Chronic Subdural Hematoma (COMPLEMENT Study)

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 600 (estimated)
• Sponsor: Kazutaka Uchida · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

COMPLEMENT study (ChrOnic subdural hematoMa Patients suppLemented with Embolization of Middle mENingeal artery Trial) is a prospective, open label, blinded endpoint (PROBE), Japanese, two-arm, randomized, controlled, post-market study to assess the efficacy and safety of middle meningeal artery embolization for chronic subdural hematoma.

Conditions

• Endovascular Treatment
• Chronic Subdural Hematoma

Interventions

Type	Name	Description
PROCEDURE	Middle meningeal artery embolization	Middle meningeal artery embolization within 7 days after randomization

Timeline

• Start date: 2024-12-23
• Primary completion: 2027-08-31
• Completion: 2029-03-31
• First posted: 2025-01-14
• Last updated: 2025-05-28

Locations

1 site across 1 country: Japan